We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-5.84%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$5.99B
AUM Growth
-$571M
Cap. Flow
-$107M
Cap. Flow %
-1.78%
Top 10 Hldgs %
12.64%
Holding
363
New
17
Increased
100
Reduced
214
Closed
10

Top Buys

Rank Stock Value
1
ACH
Accendra Health
ACH
+$32.5M
2
CHE icon
Chemed
CHE
+$26.3M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$21.6M
4
OII icon
Oceaneering
OII
+$14.8M
5
EV
Eaton Vance Corp.
EV
+$14.2M

Top Sells

Rank Stock Value
1
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
+$39.6M
2
THOR
THORATEC CORPORATION
THOR
+$27.6M
3
DTV
DIRECTV COM STK (DE)
DTV
+$26M
4
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
+$24M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$19.1M

Sector Composition

Rank Sector Weight
1 Financials 17.98%
2 Technology 15.56%
3 Healthcare 15.35%
4 Industrials 12.45%
5 Consumer Discretionary 11.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBT
326
Beacon Financial Corp
BBT
$2.51B
$424K 0.01%
+15,391
New +$435K
SVU
327
DELISTED
SUPERVALU Inc.
SVU
$423K 0.01%
8,407
– –
PDCO
328
DELISTED
Patterson Companies, Inc.
PDCO
$413K 0.01%
9,551
– –
RDS.A
329
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$411K 0.01%
8,678
-450
-5% -$24.1K
IDXX icon
330
Idexx Laboratories
IDXX
$44.9B
$401K 0.01%
5,400
– –
MRSH
331
Marsh
MRSH
$91.7B
$394K 0.01%
7,550
+500
+7% +$27.9K
BBBY
332
DELISTED
Bed Bath & Beyond Inc
BBBY
$391K 0.01%
6,850
-905
-12% -$57.7K
SO icon
333
Southern Company
SO
$109B
$353K 0.01%
7,900
– –
TMO icon
334
Thermo Fisher Scientific
TMO
$214B
$341K 0.01%
2,792
– –
ENR icon
335
Energizer
ENR
$1.5B
$335K 0.01%
8,659
-1,425
-14% -$57.1K
INGR icon
336
Ingredion
INGR
$6.48B
$332K 0.01%
3,800
– –
MA icon
337
Mastercard
MA
$497B
$288K ﹤0.01%
3,200
-985
-24% -$92.5K
BAC icon
338
Bank of America
BAC
$439B
$282K ﹤0.01%
18,102
-1,608
-8% -$27.1K
MCK icon
339
McKesson
MCK
$104B
$278K ﹤0.01%
1,501
– –
NEE icon
340
NextEra Energy
NEE
$186B
$272K ﹤0.01%
11,160
-2,436
-18% -$61.9K
BHI
341
DELISTED
Baker Hughes
BHI
$270K ﹤0.01%
5,190
– –
DD
342
DELISTED
Du Pont De Nemours E I
DD
$266K ﹤0.01%
5,515
-292
-5% -$15.6K
DD icon
343
DuPont de Nemours
DD
$19B
$259K ﹤0.01%
2,415
-51
-2% -$5.91K
EXPD icon
344
Expeditors International
EXPD
$22.4B
$256K ﹤0.01%
5,450
-500
-8% -$23.6K
UN
345
DELISTED
Unilever NV New York Registry Shares
UN
$252K ﹤0.01%
6,265
– –
NSC icon
346
Norfolk Southern
NSC
$76.1B
$251K ﹤0.01%
3,290
-325
-9% -$26.4K
NOC icon
347
Northrop Grumman
NOC
$78B
$250K ﹤0.01%
1,506
– –
PH icon
348
Parker-Hannifin
PH
$125B
$248K ﹤0.01%
2,550
– –
AMZN icon
349
Amazon
AMZN
$2.48T
$231K ﹤0.01%
+9,040
New +$229K
TEL icon
350
TE Connectivity
TEL
$62.1B
$227K ﹤0.01%
+3,785
New +$230K
11 12 13
14
15

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q3 2015 Portfolio in Review

As of Q3 2015, Boston Trust Walden held 363 positions worth $5.99B, down 8.7% from $6.56B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Trust Walden's Q3 2015 filing shows 17 new, 100 increased, 214 reduced and 10 closed positions. Its largest new stake was Accendra Health: 954,271 shares worth $30.5M. The largest sale was BIO-REFERENCE LABS INC-NEW-, an estimated $39.6M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

  • Boston Trust Walden's largest Q3 2015 buy was Accendra Health: 954,271 shares worth $30.5M.
  • Boston Trust Walden added most to Oceaneering in Q3 2015, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $19.1M.
  • Boston Trust Walden fully exited BIO-REFERENCE LABS INC-NEW- in Q3 2015, selling an estimated $39.6M.
  • Boston Trust Walden's ten largest holdings make up 13% of its $5.99B portfolio in Q3 2015.
  • Boston Trust Walden opened 17 new positions and closed 10 in Q3 2015.
  • Boston Trust Walden's portfolio value fell 8.7% quarter-over-quarter to $5.99B.

Based on Boston Trust Walden's 13F filing for Q3 2015, filed 29 Oct 2015.